Cancer Research UK is a registered charity in England and Wales (1089464), Scotland (SC041666), the Isle of Man (1103) and Jersey (247). A company limited by guarantee. Registered company in England ...

This trial is using artificial intelligence to see whether it improves quality of life questionnaires. It is for people who have cancer or had cancer in the past. Artificial intelligence (AI) allows ...

It is a treatment for neuroendocrine tumours (NETs). NETs are a type of neuroendocrine cancer. You take capecitabine as a tablet. You swallow it whole with a glass of water. You usually take the ...

People with cancer may need unplanned hospital care for many reasons. Treatment side effects or progression of the cancer itself may lead to emergency admissions. For some people, cancer is diagnosed ...

Remote consultations have become more commonplace in primary care since the COVID-19 pandemic. They present multiple challenges, as well as benefits, for health professionals and patients to navigate.

Our Recruitment Beats Cancer boards harness their networks to host prestigious events to fundraise for Cancer Research UK. Guests are treated to an evening of fine dining, networking, inspiring talks ...

Our Law Beats Cancer boards harness their networks to host prestigious events to fundraise for Cancer Research UK. Guests are treated to an evening of fine dining, networking, inspiring talks from ...

Set up a new board in your area - whatever your sector, we can help you set up a new Beats Cancer board in your area. Join one of our existing boards - we have a range of boards across the country, ...

The ampulla is part of the digestive system. It is also called the ampulla of Vater. It is where bile and pancreatic juices drain into the first part of the small bowel. Doctors call this part of the ...

Pancreatic neuroendocrine cancers develop in the neuroendocrine cells of the pancreas. Your healthcare team might call them pancreatic neuroendocrine neoplasms (NENs). But neuroendocrine cancer and ...

We're calling on everyone from researchers, to regulators, patients and the NHS to integrate fragmented efforts to realise a future where early detection and diagnosis is a routine reality. If we are ...